Form 4: Molina Healthcare Director Richard Zoretic Receives Quarterly Equity Grant

Director Richard Zoretic received 136 shares of Molina Healthcare stock on April 1, 2024, as part of the company's 2019 Equity Incentive Plan.

Summary

• Richard Zoretic, a director of Molina Healthcare, Inc., received 136 shares of common stock on April 1, 2024.
• The grant is part of the company's 2019 Equity Incentive Plan and is related to his services as a director.
• The shares were granted at a price of $404.20, which was the closing price of Molina Healthcare's common stock on that day.
• These shares are held indirectly through the Richard Charles Zoretic Revocable Living Trust.
• Following the transaction, Mr. Zoretic beneficially owns 6,459 shares indirectly.
• Jeff D. Barlow, acting as power of attorney, signed the Form 4 on April 2, 2024.

Sentiment

Score: 7

Explanation: The document reflects a routine equity grant, which is generally viewed as a neutral to slightly positive event as it aligns director interests with shareholders.

Positives

• The equity grant aligns the director's interests with those of the shareholders.
• The grant is part of a pre-determined plan, reducing concerns about insider trading.

Future Outlook

The director will continue to receive quarterly equity grants as part of the 2019 Equity Incentive Plan.

Industry Context

Director compensation through equity grants is a common practice in the healthcare industry to incentivize performance and align interests with shareholders.

Comparison to Industry Standards

• Equity grants to directors are a standard practice across publicly traded companies, including those in the healthcare sector.
• Companies like UnitedHealth Group and Cigna also utilize equity-based compensation for their board members.
• The specific amount and vesting schedule can vary based on company size, performance, and industry benchmarks.

Stakeholder Impact

• Shareholders may view the equity grant positively as it aligns the director's interests with the company's performance.
• The grant has a minimal impact on employees, customers, suppliers, and creditors.

Key Dates